RxDoctor Payments Data

Danielle Tucker

Nurse Practitioner · Westminster, CONPI 1659971448

Payments from drug & device makers

$763in general payments, 2019–2025

Across 33 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$203
  • AbbVie$150
  • Astellas Pharma US Inc$127
  • Pfizer$125
  • Urovant Sciences Inc$46
  • Hologic Sales And Service, LLC$42
  • plus $71 from 3 others

What the payments were for

  • Food & beverage$68189%
  • Education$8311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$763 in reported general payments places this provider in the 80th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$42,771
Medicare patients
156
Services billed
631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron209$145,899
GemtesaVibegron181$140,998
Estradiol236$16,275
PremarinEstrogens, Conjugated29$12,876
Fosfomycin Tromethamine15$3,404
Methenamine Hippurate23$1,560
Trimethoprim15$1,535
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst63$1,271
Cephalexin55$1,187
Fesoterodine Fumarate ErFesoterodine Fumarate13$980
YuvafemEstradiol11$896
Ciprofloxacin Hcl69$313
Solifenacin Succinate16$210
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim41$120
Fluconazole12$77

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$127$145,899209 claims
Sumitomo Pharma America, Inc.Gemtesa$39$140,998181 claims
PfizerPremarin$125$12,87629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in Westminster

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →